P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968868.83152.da |
| _version_ | 1797279929579077632 |
|---|---|
| author | Hartmut Döhner Pau Montesinos Susana Vives Polo Ewa Zarzycka Jianxiang Wang Marta Riva Michael Heuser Rodrigo Calado Andre Schuh Su-Peng Yeh Jianan Hui Diego Gianolio Prapti A Patel Christian Recher Stephane de Botton |
| author_facet | Hartmut Döhner Pau Montesinos Susana Vives Polo Ewa Zarzycka Jianxiang Wang Marta Riva Michael Heuser Rodrigo Calado Andre Schuh Su-Peng Yeh Jianan Hui Diego Gianolio Prapti A Patel Christian Recher Stephane de Botton |
| author_sort | Hartmut Döhner |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:33:56Z |
| format | Article |
| id | doaj.art-de84a0d76ef942b08f1b1492c7aa6d27 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:33:56Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-de84a0d76ef942b08f1b1492c7aa6d272024-03-03T10:07:30ZengWileyHemaSphere2572-92412023-08-017e83152da10.1097/01.HS9.0000968868.83152.da202308003-00391P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINEHartmut Döhner0Pau Montesinos1Susana Vives Polo2Ewa Zarzycka3Jianxiang Wang4Marta Riva5Michael Heuser6Rodrigo Calado7Andre Schuh8Su-Peng Yeh9Jianan Hui10Diego Gianolio11Prapti A Patel12Christian Recher13Stephane de Botton141 Ulm University Hospital, Department of Internal Medicine III, Ulm, Germany2 Hospital Universitari i Politècnic La Fe, Servicio de Hematología y Hemoterapia, València, Spain3 Josep Carreras Research Institute,, Hospital Universitario Germans Trias i Pujol-ICO Badalona, Badalona, Spain4 Medical University of Gdansk, Department of Hematology and Transplantology, Gdańsk, Poland5 Peking Union Medical College, Institute of Hematology & Hospital of Blood Disease, Tianjin, China6 ASST Grande Ospedale Metropolitano Niguarda, Department of Hematology, Oncology and Molecular Medicine, Milan, Italy7 Hannover Medical School, Hannover, Germany8 University of São Paulo, Ribeirão Preto School of Medicine, São Paulo, Brazil9 Princess Margaret Cancer Centre, Toronto, Canada10 China Medical University, Taichung, Taiwan11 Servier Pharmaceuticals, Boston, United States11 Servier Pharmaceuticals, Boston, United States11 Servier Pharmaceuticals, Boston, United States12 Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France13 Institut Gustave Roussy, Villejuif, Francehttp://journals.lww.com/10.1097/01.HS9.0000968868.83152.da |
| spellingShingle | Hartmut Döhner Pau Montesinos Susana Vives Polo Ewa Zarzycka Jianxiang Wang Marta Riva Michael Heuser Rodrigo Calado Andre Schuh Su-Peng Yeh Jianan Hui Diego Gianolio Prapti A Patel Christian Recher Stephane de Botton P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE HemaSphere |
| title | P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE |
| title_full | P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE |
| title_fullStr | P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE |
| title_full_unstemmed | P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE |
| title_short | P490: UPDATED SURVIVAL, BLOOD COUNT RECOVERY AND SAFETY RESULTS FROM THE AGILE STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE |
| title_sort | p490 updated survival blood count recovery and safety results from the agile study in patients with acute myeloid leukemia treated with ivosidenib azacitidine compared to placebo azacitidine |
| url | http://journals.lww.com/10.1097/01.HS9.0000968868.83152.da |
| work_keys_str_mv | AT hartmutdohner p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT paumontesinos p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT susanavivespolo p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT ewazarzycka p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT jianxiangwang p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT martariva p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT michaelheuser p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT rodrigocalado p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT andreschuh p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT supengyeh p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT jiananhui p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT diegogianolio p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT praptiapatel p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT christianrecher p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine AT stephanedebotton p490updatedsurvivalbloodcountrecoveryandsafetyresultsfromtheagilestudyinpatientswithacutemyeloidleukemiatreatedwithivosidenibazacitidinecomparedtoplaceboazacitidine |